Long COVID in Children and Adolescents

Click here to read the PCC CME article 

Overview

Long COVID symptoms are both physical and mental in nature among children and adolescents and have the potential to affect long-term functioning and increase the overall burden on health care delivery.

Learning Objective 

Monitor children and adolescents for symptoms of long COVID using multidisciplinary approaches

Target Audience

Primary care clinicians

Read the whole article at psychiatrist.com here: 
Long COVID in Children and Adolescents 

© Copyright 2022 Physicians Postgraduate Press, Inc.

Target Audience

Primary care clinicians

Learning Objectives

Monitor children and adolescents for symptoms of long COVID using multidisciplinary approaches

Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Activity opens: 
04/26/2022
Activity expires: 
04/30/2023
Cost:
$0.00

CME Background

Articles are selected for credit designation based on an assessment of the educational needs of CME participants, with the purpose of providing readers with a curriculum of CME articles on a variety of topics throughout each volume. Activities are planned using a process that links identified needs with desired results.

CME Objective

After studying this article, you should be able to:

  • Monitor children and adolescents for symptoms of long COVID using multidisciplinary approaches 

Statement of Need and Purpose

Neuropsychiatric manifestations following COVID-19 infection are widely accepted in adults, and emerging evidence supports the presence of long COVID in children and adolescents. Recent studies have recognized the challenges in distinguishing long-term symptoms caused by COVID-19 infection from pandemic-related symptoms. Practitioners need education about monitoring children and adolescents for symptoms of long COVID so that they can be mitigated as early as possible; thus, improving patient outcomes. Education is needed on the role of clinical monitoring with multidisciplinary approaches for physical problems, reasonable academic accommodations, preventive vaccinations, and mental health support.

Release, Expiration, and Review Dates

This educational activity was published in April 2022 and is eligible for AMA PRA Category 1 Credit™ through April 30, 2023. The latest review of this material was April 2022.

Disclosure of Off-Label Usage

The authors have determined that, to the best of their knowledge, no investigational information about pharmaceutical agents or device therapies that is outside US Food and Drug Administration–approved labeling has been presented in this activity.

Funding/Support

None.

Faculty Affiliation


Mayank Gupta, MD
Clarion Psychiatric Center, Clarion, Pennsylvania



Nihit Gupta, MD
Reynolds Memorial Hospital, Glendale, West Virginia



Michael Esang, MD
Clarion Psychiatric Center, Clarion, Pennsylvania

 

*Corresponding authors: Mayank Gupta, MD, Clarion Psychiatric Center, 2 Hospital Drive, Clarion, PA 16214 (mayank6nov@gmail.com).

Financial Disclosure 

All individuals in a position to influence the content of this activity were asked to complete a statement regarding all relevant personal financial relationships between themselves or their spouse/partner and any commercial interest. The CME Institute has resolved any conflicts of interest that were identified. In the past year, Larry Culpepper, MD, MPH, Editor in Chief of The Primary Care Companion for CNS Disorders, has been a consultant for AbbVie, Acadia, Allergan, Eisai, Merck, and Takeda; has been a stock shareholder of M-3 Information; and has received royalties from UpToDate and Oxford University Press. No member of the CME Institute staff reported any relevant personal financial relationships.

Relevant financial relationships: Drs M. Gupta, N. Gupta, and Esang have no personal affiliations or financial relationships with any commercial interest to disclose relative to this article.

Accreditation Statement

The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

The CME Institute of Physicians Postgraduate Press, Inc., designates this journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this activity.

Register for free on our site to participate in this and many free CME courses. 

Available credit: 

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Learning Objective 

Monitor children and adolescents for symptoms of long COVID using multidisciplinary approaches

Target Audience

Primary care clinicians

Read the whole article at psychiatrist.com here: 
Long COVID in Children and Adolescents